Polymorphs Of An Ssao Inhibitor

Abstract: Provided herein are polymorphs of (2E)-3-fluoro-2-({[2-( 4-methoxypiperidin- 1 - yl)pyrimidin-5-yl]oxy}methyl)prop-2-en-1-aminium 4-methylbenzenesulfonate, compositions thereof, methods of preparation thereof, and methods of use thereof.

Patent Information

Application #

Filing Date

22 March 2023

Publication Number

47/2023

Publication Type

INA

Invention Field

CHEMICAL

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

Lilly Corporate Center Indianapolis, Indiana 46285

Inventors

1. REMICK, David Michael

c/o Eli Lilly and Company Lilly Corporate Center Indianapolis, Indiana 46285

Specification

Documents

Application Documents

#	Name	Date
1	202317019823.pdf	2023-03-22
2	202317019823-STATEMENT OF UNDERTAKING (FORM 3) [22-03-2023(online)].pdf	2023-03-22
3	202317019823-PROOF OF RIGHT [22-03-2023(online)].pdf	2023-03-22
4	202317019823-PRIORITY DOCUMENTS [22-03-2023(online)].pdf	2023-03-22
5	202317019823-FORM 1 [22-03-2023(online)].pdf	2023-03-22
6	202317019823-DRAWINGS [22-03-2023(online)].pdf	2023-03-22
7	202317019823-DECLARATION OF INVENTORSHIP (FORM 5) [22-03-2023(online)].pdf	2023-03-22
8	202317019823-COMPLETE SPECIFICATION [22-03-2023(online)].pdf	2023-03-22
9	202317019823-FORM-26 [05-05-2023(online)].pdf	2023-05-05
10	202317019823-FORM 3 [18-09-2023(online)].pdf	2023-09-18